The extract from Agkistrodon halys venom protects against lipopolysaccharide (LPS)-induced myocardial injury

BMC Complement Altern Med. 2019 Jul 17;19(1):176. doi: 10.1186/s12906-019-2595-4.

Abstract

Background: Snake venoms contain various bioactive constituents which possess potential therapeutic effects. The aim of this work was to investigate the effect of the extract from Agkistrodon halys venom on lipopolysaccharide (LPS)-induced myocardial injury.

Methods: Thirty male Sprague-Dawley rats were randomly assigned to three groups (10 rats per group): control group, LPS group and LPS + extract group. Rats in control and the LPS groups were intravenously injected with sterile saline solution, and rats in the LPS + extract group with the extract. After 2 h, rats of the control group were intraperitoneally injected sterile saline solution, and rats in the LPS and the LPS + extract groups were treated with LPS (20 mg per kg body weight). Levels of creatine kinase (CK) and lactate dehydrogenase (LDH) in serum were determined. Anti-inflammation of the extract was analyzed via determination of TNF-α and IL-6 in serum, and expression of TNF-α, IL-6, COX-2 and p-ERK protein in hearts. Heme oxygenase-1 (HO-1) and p-NF-κB protein expression in hearts, superoxide dismutase (SOD) activity and malondialdehyde (MDA) level in serum were used to evaluate the anti-oxidative properties of the extract.

Results: Extract pretreatment significantly decreased the level of serum CK and LDH, reduced the generation of inflammatory cytokines such as TNF-α and IL-6, and also reduced serum level of MDA in the LPS + extract group compared with the LPS group. In addition, the extract increased SOD activity in serum, HO-1 protein expression in hearts, and decreased TNF-α, IL-6, COX-2, p-NF-κB and p-ERK1/2 protein expression.

Conclusion: Our results suggested that beneficial effect of this extract might be associated with an improved anti-oxidation and anti-inflammatory effect via downregulation of NF-κB/COX-2 signaling by activating HO-1/CO in hearts.

Keywords: Agkistrodon halys venom; LPS; Myocardial injury.

MeSH terms

  • Agkistrodon / metabolism*
  • Animals
  • Heart / drug effects
  • Heart Injuries / chemically induced
  • Heart Injuries / genetics
  • Heart Injuries / metabolism
  • Heart Injuries / prevention & control*
  • Heme Oxygenase-1 / genetics
  • Heme Oxygenase-1 / metabolism
  • Humans
  • Interleukin-6 / genetics
  • Interleukin-6 / metabolism
  • Lipopolysaccharides / adverse effects*
  • Male
  • Malondialdehyde / metabolism
  • NF-kappa B / genetics
  • NF-kappa B / metabolism
  • Protective Agents / administration & dosage*
  • Rats
  • Rats, Sprague-Dawley
  • Snake Venoms / administration & dosage*
  • Superoxide Dismutase / genetics
  • Superoxide Dismutase / metabolism

Substances

  • Interleukin-6
  • Lipopolysaccharides
  • NF-kappa B
  • Protective Agents
  • Snake Venoms
  • Malondialdehyde
  • Heme Oxygenase-1
  • Superoxide Dismutase